Apex Biotechnology (TPE:1733) Other Net Income (Loss) : NT$0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Apex Biotechnology Other Net Income (Loss)?

Apex Biotechnology's Other Net Income (Loss) for the three months ended in Mar. 2024 was NT$0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was NT$0 Mil.

Apex Biotechnology's quarterly Other Net Income (Loss) declined from Sep. 2023 (NT$0 Mil) to Dec. 2023 (NT$-0 Mil) but then increased from Dec. 2023 (NT$-0 Mil) to Mar. 2024 (NT$0 Mil).

Apex Biotechnology's annual Other Net Income (Loss) increased from Dec. 2021 (NT$-0 Mil) to Dec. 2022 (NT$0 Mil) and increased from Dec. 2022 (NT$0 Mil) to Dec. 2023 (NT$0 Mil).

Apex Biotechnology Other Net Income (Loss) Historical Data

The historical data trend for Apex Biotechnology's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apex Biotechnology Other Net Income (Loss) Chart

Apex Biotechnology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Apex Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Apex Biotechnology Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0 Mil.

Apex Biotechnology Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Apex Biotechnology's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Apex Biotechnology (TPE:1733) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apex Biotechnology Corp (TPE:1733) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.7, Li-Hsin 5th Road, Hsinchu Science Park, Hsinchu, TWN, 30078

Website

https://www.apexbio.com

Apex Biotechnology Corp engages mainly in research, development, production, manufacturing and selling of biochemical testing instruments and its detection strips, and trade of products and components relevant to the core business. The company develops and markets biosensor-based blood glucose monitoring systems. The company manufactures non-invasive diagnostic technologies, IT-based telehealth care and molecular diagnostic and traditional Chinese medicine. Its product offerings include Eclipse plus multipurpose analyzer, Glucosure HT blood glucose monitoring system, HemoSmart GOLD hemoglobin screening system among others.

Apex Biotechnology (TPE:1733) Headlines

No Headlines